The isoflavonoid aglycone-rich fractions of Chungkookjang, fermented unsalted soybeans, enhance insulin signaling and peroxisome proliferator- activated receptor-γ activity in vitro

BioFactors

Volumn 26, Issue 4, 2006, Pages 245-258

  Kwon, Dae Young ^a   Jang, Jin Sun ^b   Lee, Ji Eun ^b   Kim, Yong Suk ^c   Shin, Dong Hwa ^c   Park, Sunmin ^b  

^a Korea Food Research Institute   (South Korea)

^b Hoseo University   (South Korea)

^c Chonbuk National University   (South Korea)

Author keywords

Fermented soybeans; Glucose stimulated insulin secretion; Insulin sensitizing; PPAR agonist

Indexed keywords

AGLYCONE; CHUNGKOOKJANG EXTRACT; DAIDZEIN; DAIDZIN; GENISTEIN; GENISTIN; GLUCOSE; GLUCOSE TRANSPORTER 4; GLYCITEIN; GLYCITIN; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; ISOFLAVONOID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLANT EXTRACT; POLACRILIN; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ANTIDIABETIC ACTIVITY; ARTICLE; BACILLUS SUBTILIS; CANCER CELL; CELL MEMBRANE; CHUNGKOOKJANG; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; COOKED FOOD; DRUG ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; EMBRYO; FERMENTATION; FRACTIONATION; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; IN VITRO STUDY; INSULIN METABOLISM; INSULIN RELEASE; INSULINOMA; MOUSE; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR INTRINSIC ACTIVITY; SIGNAL TRANSDUCTION; SOYBEAN;

3T3-L1 CELLS; ADIPOCYTES; ALPHA-AMYLASE; ANIMALS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FERMENTATION; GLUCOSE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; ISOFLAVONES; MICE; PPAR GAMMA; SIGNAL TRANSDUCTION; SOYBEANS; TRIGLYCERIDES;

BACILLUS SUBTILIS; GLYCINE MAX;

EID: 33751084315     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520260403     Document Type: Article

References (31)

1. D.R. Alessi and P. Cohen, Mechanism of activation and function of protein kinase, Current Opinions Genetic Development 8 (1998), 55-62.
2. J. Berger, P. Bailey, C. Biswas, C.A. Cullinan, T.W. Doebber, N.S. Hoyes, R. Saperstein, R.G. Smith and M.D. Leibowitz, Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-γ: binding and activation correlate with antidiabetic actions in db/db mice, Endocrinology 137 (1996), 4189-4195.
3. S.J. Bhathena and M.T. Velasquez, Beneficial role of dietary phytoestrogens in obesity and diabetes, American Journal of Clinical Nutrition 76 (2002), 1191-1201.
4. K.K. Carroll and E.M. Kurowska, Soy consumption and cholesterol reduction: review of animal and human studies, Journal of Nutrition 125 (1995), 594S-597S.
5. S.B. Choi, D.W. Jun and S. Park, The insulin sensitizing effect of homoisoflavone-enriched fraction in Liriope platyphylla Wang et Tang via PI3-kinase pathway, Life Science 75 (2004), 2653-2664.
6. S.B. Choi and S. Park, The effects of water extract of Polygonatum Odoratum (Mill) Druce on insulin resistance in 90% pancreatectomized rats, Journal of Food Science 67 (2002), 2375-2379.
7. Committee of SAS Institute, Guide for personal computers, SAS Institutes Inc., Cary, NC, 1985, 257-260.
8. H. Fujita, T. Yamagami and K. Ohshima, Fermented soybean - derived water-soluble Touchi extract inhibits β-glucosidase and is antiglycemic in rats and humans after single oral treatments, Journal of Nutrition 131 (2001), 1211-1213.
9. M. Fukutake, M. Takahashi, K. Ishida, H. Kawamura, T. Sugimura and K. Wakabayashi, Quantification of genistein and genistin in soybeans and soybean products, Food and Chemical Toxicology 34 (1996), 457-461.
10. S. Hallakou, L. Doare, F. Foufelle, M. Kergoat, M. Guerre-Millo, M.F. Berthault, I. Dugail, J. Morin, J. Auwerx and P. Ferre,. Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat, Diabetes 46 (1997), 1393-1399.
11. K. Hermansen, M. Sondergaard, L. Hoie, M. Carstensen and B. Brock, Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects, Diabetes Care 24 (2001), 228-233.
12. G.G. Holz and O.G. Chepurny, Glucagon-like peptide-1 synthetic analogs: new therapeutic agents for use in the treatment of diabetes mellitus, Current Medical Chemistry 10 (2003), 2471-2483.
13. P.M. Jones and S.J. Pesaud, Tyrosine kinase inhibitors inhibit glucose-stimulated insulin secretion, Biochemical Society Transactions 22 (1994), 209S-211S.
14. S.E. Kahn, The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes, Diabetologia 46 (2003), 3-19.
15. K. Kotani, W. Ogawa, M. Hashiramoto, T. Onishi, S. Ohno and M. Kasuga, Inhibition of insulin-induced glucose uptake by atypical protein kinase C isotype-specific interacting protein in 3T3-L1 adipocytes, Journal of Biological Chemistry 275 (2000), 26390-26395.
16. P. Mackowiak, L. Nagowski and K.W. Nowak, Effect of isoflavone genistein on insulin receptors in perfused liver of ovariectomized rats, Journal of Receptor Signal Transduction Research 19 (1999), 283-292.
17. J. Matsui, Y. Terauchi, N. Kubota, I. Takamoto, K. Eto, T. Yamashita, K. Komeda, T. Yamauchi, J. Kamon, S. Kita, M. Noda and T. Kadowaki, Pioglitazone reduces islet triglyceride content and restores impaired glucose-stimulated insulin secretion in heterozygous peroxisome proliferator-activated receptor-gamma-deficient mice on a high-fat diet, Diabetes 53 (2004), 2844-2854.
18. O. Mezei, W.J. Banz, R.W. Steger, M.R. Peluso, T.A. Winters and N. Shay, Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells, Journal of Nutrition 133 (2003), 1238-1243.
19. Y. Miyazaki, A. Mahankali, E. Wajcberg, M. Bajaj, L.J. Mandarino and R.A. DeFronzo, Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients, Journal of Clinical Endocrinology and Metabolism 89 (2004), 4312-4319.
20. N. Nakajima, N. Nozaki, K. Ishihara, A. Ishikawa and H. Tsuji, Analysis of isoflavone content in tempeh, a fermented soybean, and preparation of a new isoflavone-enriched tempeh, Journal of Bioscience Bioengineering 100 (2005), 685-687.
21. Y. Nakamura, S. Tsuji and Y. Tonogai, Determination of the levels of isoflavonoids in soybeans and soy-derived foods and estimation of isoflavonoids in the Japanese daily intake, Journal of AOAC International 83 (2000), 635-650.
22. T. Ohno, N. Kato, C. Ishii, M. Shimizu, Y. Ito, S. Tomono and S. Kawazu, Genistein augments cyclic adenosine 3′5′-monophosphate (cAMP) accumulation and insulin release in MIN6 cells, Endocrine Research 19 (1993), 273-285.
23. A. Okuno, H. Tamemoto, K. Tobe, K. Ueki, Y. Mori, K. Iwamoto, K. Umesono, Y. Akanuma, T. Fujiwara, H. Horikoshi, Y. Yazaki and T. Kadowaki, Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats, Journal of Clinical Investigation 101 (1998), 1354-1361.
24. S. Park, X. Dong, T.L. Fisher, S. Dunn, A.K. Omer, G. Weir and W.F. White, Exendin-4 uses Irs2 signaling to mediate pancreatic beta cell growth and function, Journal of Biological Chemistry 281 (2006), 1159-1168.
25. G. Perseghin, A. Caumo, C. Arcelloni, S. Benedini, R. Lanzi, E. Pagliato, L.P. Sereni, G. Testolin, A. Battezzati, G. Comi, M. Comola and L. Luzi, Contribution of abnormal insulin secretion and insulin resistance to the pathogenesis of type 2 diabetes in myotonic dystrophy, Diabetes Care 26 (2003), 2112-2118.
26. H. Schagger and G. Von Jacow, Tricine-sodium dodecyl sulfate- polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa, Analytical Biochemistry 166 (1987), 368-379.
27. R.K. Semple, V.K. Chatterjee and S. O'Rahilly, PPARgamma and human metabolic disease, Journal of Clinical Investigation 116 (2006), 581-589.
28. A. Shimaya, K.S. Kovacina and R.A. Roth, On the mechanism for neomycin reversal of wortmannin inhibition of insulin stimulation of glucose uptake, Journal of Biological Chemistry 279 (2004), 55277-55282.
29. J.L. Slavin, S.C. Karr, A.M. Hutchins and J.W. Lampe, Influence of soybean processing, habitual diet and soy dose on urinary isoflavonoid excretion, American Journal of Clinical Nutrition 68 (1998), S1492-S1495.
30. R.L. Sorenson, T.C. Brelje and C. Roth, Effect of tyrosine kinase inhibitors on islets of Langerhans: evidence for tyrosine kinases in the regulation of insulin secretion, Endocrinology 134 (1994), 1975-1978.
31. K. Vedavanam, S. Srijayanta, J. O'Reilly, A. Raman and H. Wiseman, Antioxidant action and potential antidiabetic properties of an isoflavonoid-containing soyabean phytochemical extract (SPE), Phytotherapy Research 13 (1999), 601-608.